Diabetes Insights - Breakthroughs and Innovators

In this episode, Prof. João Filipe Raposo (Portugal) and Prof. Harald Sourij (Austria) join Vivienne Parry to debate one of the most discussed topics in modern diabetes care: the role of artificial intelligence. The conversation explores how AI is already being used to support diabetes management, including automated insulin delivery systems, continuous glucose monitoring and risk prediction. At t...

In this episode, EASD tv host Vivienne Parry speaks with Prof. Daisuke Yabe (Kyoto University) about the growing global impact of EASD and the importance of international collaboration in diabetes research. Prof. Yabe explains the key differences between diabetes phenotypes in Europe and East Asia, highlighting how obesity, insulin resistance and beta cell dysfunction vary across populations. He d...

In this episode, Prof. Thomas Karagiannis and Dr Francesco Zaccardi take us behind the scenes of clinical guideline development at EASD. As methodologists involved in creating the first EASD clinical guidelines, they explain how rigorous evidence review, transparent processes and careful management of conflicts of interest help ensure recommendations are trustworthy and evidence-based. The discuss...

In this episode, Dame Melanie Davies and Prof. Amanda Adler discuss the development of a new EASD clinical guideline on continuous glucose monitoring (CGM) in people living with type 2 diabetes. As CGM becomes increasingly available, clinicians, researchers, and policymakers are seeking clear evidence-based guidance on its role in diabetes management. The discussion explores why CGM was selected a...

In this episode, Prof. Eberhard Standl marks an extraordinary milestone - 50 years since attending his first EASD Congress. Looking back on a career spanning five decades, he shares how diabetes care has evolved from the challenges of diabetic ketoacidosis in the 1970s to today's advances in continuous glucose monitoring, hybrid closed-loop systems, immunotherapies, and the potential reversal of t...

In this episode, Prof. Richard Holt and Prof. Kirsten Nørgaard discuss the updated EASD-ADA Consensus Report on Type 1 Diabetes, a comprehensive update designed to provide timely, evidence-based guidance for healthcare professionals managing type 1 diabetes. They explain how consensus reports differ from formal clinical guidelines, why they remain an important tool for advancing diabetes care, and...

In this episode, Prof. Partha Kar joins EASD TV Host, Vivienne Parry, to explore the growing role of social media in healthcare and diabetes care. From combating misinformation and amplifying patient voices to navigating online abuse and professional risks, Prof. Kar shares why he believes clinicians should engage - not retreat - from digital platforms. He discusses how social media helped shape c...

In this episode, Prof. Steven Kahn, Editor-in-Chief of Diabetes Care, and Deputy Editor Dr John Buse discuss their powerful editorial examining how political decisions, healthcare reform, and attacks on diversity, equity, and inclusion (DEI) could impact diabetes care and biomedical research in the United States and globally. The conversation explores concerns around cuts to NIH and CDC funding, c...

In this episode, leading experts from international endocrine and diabetes organisations discuss newly launched guidelines on diabetes and pregnancy. The conversation explores the importance of preconception care, nutrition during pregnancy, the use of metformin and GLP-1 therapies, continuous glucose monitoring (CGM), and the often-overlooked postpartum period. With growing numbers of women livin...

In this episode, Bastian Hauck and Renza Scibilia from the Dedoc° explore how lived experience is reshaping the future of diabetes care. Once excluded from scientific discussions, people living with diabetes are now playing a central role in research, clinical guidelines, and innovation. From contributing to EASD guideline development to sharing global perspectives in leading journals, patient voi...

In this episode, experts in diabetes and virology, Profs. Knut Dahl-Jørgensen (University of Oslo), Heikki A. Hyöty (Tampere University), and Decio L. Eizirik (Université Libre de Bruxelles), explore the long-debated link between viral infections and type 1 diabetes. With new technologies enabling the detection of viruses at unprecedented sensitivity, the evidence connecting enteroviruses - partic...

In this episode, members of the EASD Global Council, Dr. Fawaz Alzaid and Dr. Banshi Saboo, share their perspectives on the global challenges of diabetes, highlighting how regional differences shape both risk and care. From the Middle East to South Asia, they explore how factors such as climate, diet, and socioeconomic conditions influence diabetes prevalence and outcomes. The discussion delves in...

In this episode, leading experts Dr. Daniela Liśkiewicz and Dr. Juan Pablo Frías explore the rapidly evolving landscape of anti-obesity medications. From the rise of GLP-1-based therapies and oral treatments to next-generation multi-agonists, this discussion highlights how innovation is transforming obesity care. The conversation moves beyond weight loss alone, focusing on treatment quality, long-...

In this episode, leading experts Maciej T. Małecki, Norbert Hermanns and Dominic Ehrmann explore the essential role of clinical psychology in diabetes care. Living with diabetes, particularly type 1 diabetes, requires constant decision-making and places a significant psychological burden on individuals and their families. From diabetes distress and depression to fear of hypoglycaemia, mental healt...

In this episode, we explore the rapidly evolving world of scientific publishing and the challenges facing researchers today, featuring insights from Diabetologia Editor in Chief Prof. Hindrik Mulder, Maria Hodges, Past EASD Early Career Member Pierre Larraufie and Annette Schürmann. From the rise of predatory journals and paper mills to the growing influence of artificial intelligence, the landsca...

In this episode, Prof. Chantal Mathieu and Prof. Francesco Dotta discuss two major European clinical trials presented at the EASD Annual Meeting: MELD-ATG and VERA-T1D. Both studies were conducted through the INNODIA consortium, a large European collaboration aimed at identifying biomarkers and testing new disease-modifying therapies for type 1 diabetes. The VERA-T1D trial investigated verapamil,...

In this episode, members of the EASD Committee on Clinical Affairs (CCA) discuss how clinical guidance is developed, reviewed and translated into real-world practice. CCA Chair, Prof. Richard Holt and Prof. Anne Peters explore the production of consensus reports, expert opinion documents and the EASD’s new guideline programme. They discuss the first EASD guideline on diabetes distress, the upcomin...

In this episode, Prof. Nita Forouhi (University of Cambridge) and Prof. Michael Lean (University of Glasgow) explore the science behind nutrition, weight loss and type 2 diabetes remission. They discuss the role of ultra-processed foods, meat consumption and the importance of whole-food, minimally processed diets. The conversation highlights groundbreaking research showing that substantial, intent...

In this episode, experts from the University of Amsterdam (Prof. J. Hans de Vries), the University of Newcastle (Prof. James A.M. Shaw) and Deakin University (Prof. Jane Speight) explore one of the most feared complications of type 1 diabetes: severe hypoglycaemia. While advances in continuous glucose monitoring and automated insulin delivery have reduced severe episodes by around 40%, they have n...

In this episode, Prof. Gill Livingston (University College London) and Prof. Thomas van Sloten (UMC Utrecht) explore the complex relationship between diabetes and dementia. People with diabetes face a higher risk of cognitive decline, particularly those with type 2 diabetes, and as treatment improves and life expectancy increases, dementia is becoming a growing clinical challenge. The discussion e...

In this episode, Professor Francesco Giorgino (EASD President) and Professor Leszek Czupryniak (EASD Global Council Advisor) introduce EASD's newest initiative: the Global Council, launched in Madrid in 2023. This 13-member council brings together diabetes experts from Asia, North and South America, Africa, the Middle East, Australia, and underrepresented regions of Europe to provide direct, activ...

In this episode, a cardiologist, an epidemiologist and a diabetologist come together to discuss the deep and evolving links between diabetes and cardiovascular disease. The conversation explores heart failure as a common but often under-recognized complication of diabetes, how cardiovascular risk begins even before type 2 diabetes develops, and why modern therapies increasingly target multiple org...

In this episode, Prof. Frédéric Gachon and Prof. Olga Pivovarova-Ramich explore how the timing of eating and exercise influences metabolism and diabetes risk. Drawing on recent research in chronobiology, they discuss circadian rhythms, chronotype, late-night eating, intermittent fasting, and how aligning daily behaviours with our internal clocks may improve metabolic health and insulin sensitivity...

In this weeks episode of Diabetes Insights - Breakthroughs and Innovators, experts discuss the highly anticipated SURPASS CVOT trial, a head-to-head cardiovascular outcomes study comparing tirzepatide 15 mg weekly with dulaglutide 1.5 mg weekly in people with type 2 diabetes. With over 13,000 participants, the trial demonstrates that tirzepatide provides equivalent cardioprotective benefits to dul...

In our first episode of 2026, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, offers a journal’s-eye view of the most exciting and challenging developments in diabetes research today. Drawing on his unique overview of submissions from across the global research community, prof. Mulder discusses emerging breakthroughs such as hypoimmune stem cell-based therapies that are transforming from th...